By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


 

SIGA Technologies, Inc. 

420 Lexington Avenue
Suite 620
New York  New York  10170  U.S.A.
Phone: 212-672-9100 Fax: 212-697-3130


SEARCH JOBS


Industry
Biotechnology

Segment
Gene Therapy





Company News
SIGA (SIGA) Announces Bankruptcy Court Approval Of Transaction Under Which SIGA Will Pay PharmAthene, Inc. (PIP) Claim In Full 9/21/2016 8:59:53 AM
PharmAthene, Inc. (PIP) Announces Receipt Of Payments From SIGA (SIGA) 9/16/2016 6:51:34 AM
SIGA (SIGA) Announces Completion Of Enrollment And Dosing In The Final Cohort Of Phase III Study Of TPOXX (Tecovirimat) 8/30/2016 11:42:18 AM
SIGA (SIGA) Announces Data Safety Monitoring Board (DSMB) Approval To Complete Subject Enrollment In The Final Cohort Of Phase III Study Of TPOXX (Tecovirimat) 8/9/2016 10:23:08 AM
PharmAthene, Inc. (PIP) Receives $20 Million Payment From SIGA (SIGA) To Extend Payment Deadline 7/11/2016 6:27:26 AM
SIGA (SIGA) Announces Enrollment Of First Patients In The Final Cohort Of Phase III Study Of Tecovirimat 4/26/2016 12:36:12 PM
SIGA (SIGA) Successfully Emerges from Chapter 11 4/13/2016 6:01:00 AM
SIGA (SIGA) Commences Clinical Study For Intravenous (IV) Formulation Of TPOXX 3/17/2016 8:21:55 AM
FDA Concurs On Clinical Dose For SIGA (SIGA)’s Tecovirimat Antiviral 2/24/2016 11:25:19 AM
SIGA (SIGA) Announces That Delaware Supreme Court Affirms Court Of Chancery Opinion 12/28/2015 12:22:57 PM
12345678910...
//-->